Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Aspen Pharmacare
Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Aspen’s market slump wipes $52 million from South African tycoon Gus Attridge’s stake
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
Aspen’s 20-percent stock decline costs South African tycoon Stephen Saad nearly $160 million
Saad's wealth drops by nearly $160 million after Aspen Pharmacare's shares tumble 20.17 percent over the past 25 days on the JSE.
South African billionaire Stephen Saad loses $28 million in one week
This follows a gain of $32.2 million recorded between April 23 and May 1, when his stake increased from $654.18 million to $686.41 million.
South African tycoon Gus Attridge rakes in $6.2 million from Aspen shares
This follows a $12 million gain recorded between April 23 and May 3, when his stake rose from R4.07 billion ($219.65 million) to R4.29 billion ($231.65 million).
South African tycoon Gus Attridge gains nearly $12 million from Aspen shares
Attridge, Aspen’s group chief advisor, and a JSE heavyweight, holds a 4.3-percent stake in the pharmaceutical company, amounting to 19,033,829 ordinary shares.
South African billionaire Stephen Saad’s Aspen to boost global supply of obesity medication
Aspen, Africa’s largest drugmaker, is actively exploring ways to ramp up the availability of these in-demand treatments worldwide.
South African tycoon Gus Attridge gains $7.95 million from Aspen shares
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake in Aspen grew by R447.12 million ($25.12 million).
South African billionaire Stephen Saad gains $21.1 million as Aspen shares soar
This rise in Saad’s stake underscores his pivotal role in South Africa’s business landscape, placing him among the top investors on the JSE.
South African billionaire Stephen Saad leads Aspen to record $1.1-billion revenue
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active pharmaceutical ingredients (API) business.
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
South African billionaire Stephen Saad gains $49 million as Aspen shares soar
This increase cements Saad’s position in the South African business scene, placing him among the leading investors on the JSE.